These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats. Torregrossa MM; Folk JE; Rice KC; Watson SJ; Woods JH Psychopharmacology (Berl); 2005 Nov; 183(1):31-40. PubMed ID: 16220339 [TBL] [Abstract][Full Text] [Related]
5. Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies. Zhang H; Shi YG; Woods JH; Watson SJ; Ko MC Eur J Pharmacol; 2007 Sep; 570(1-3):89-96. PubMed ID: 17601558 [TBL] [Abstract][Full Text] [Related]
6. Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats. Broom DC; Jutkiewicz EM; Folk JE; Traynor JR; Rice KC; Woods JH Psychopharmacology (Berl); 2002 Oct; 164(1):42-8. PubMed ID: 12373418 [TBL] [Abstract][Full Text] [Related]
7. Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats. Jutkiewicz EM; Rice KC; Traynor JR; Woods JH Psychopharmacology (Berl); 2005 Nov; 182(4):588-96. PubMed ID: 16163520 [TBL] [Abstract][Full Text] [Related]
8. Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects. Jutkiewicz EM; Torregrossa MM; Sobczyk-Kojiro K; Mosberg HI; Folk JE; Rice KC; Watson SJ; Woods JH Eur J Pharmacol; 2006 Feb; 531(1-3):151-9. PubMed ID: 16442521 [TBL] [Abstract][Full Text] [Related]
9. Comparison of peptidic and nonpeptidic delta-opioid agonists on guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding in brain slices from Sprague-Dawley rats. Jutkiewicz EM; Walker NP; Folk JE; Rice KC; Portoghese PS; Woods JH; Traynor JR J Pharmacol Exp Ther; 2005 Mar; 312(3):1314-20. PubMed ID: 15574687 [TBL] [Abstract][Full Text] [Related]
10. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat. Gyires K; Rónai AZ J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923 [TBL] [Abstract][Full Text] [Related]
11. Propofol pretreatment increases antidepressant-like effects induced by acute administration of ketamine in rats receiving forced swimming test. Wang X; Yang Y; Zhou X; Wu J; Li J; Jiang X; Qu Q; Ou C; Liu L; Zhou S Psychiatry Res; 2011 Jan; 185(1-2):248-53. PubMed ID: 20580983 [TBL] [Abstract][Full Text] [Related]
12. Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. Broom DC; Jutkiewicz EM; Folk JE; Traynor JR; Rice KC; Woods JH Neuropsychopharmacology; 2002 Jun; 26(6):744-55. PubMed ID: 12007745 [TBL] [Abstract][Full Text] [Related]
13. Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Russo-Neustadt A; Ha T; Ramirez R; Kesslak JP Behav Brain Res; 2001 Apr; 120(1):87-95. PubMed ID: 11173088 [TBL] [Abstract][Full Text] [Related]
14. Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test. Huang P; Tunis J; Parry C; Tallarida R; Liu-Chen LY Eur J Pharmacol; 2016 Jun; 781():53-9. PubMed ID: 27044434 [TBL] [Abstract][Full Text] [Related]
15. The hydrophobic dipeptide Leu-Ile inhibits immobility induced by repeated forced swimming via the induction of BDNF. Furukawa-Hibi Y; Nitta A; Ikeda T; Morishita K; Liu W; Ibi D; Alkam T; Nabeshima T; Yamada K Behav Brain Res; 2011 Jul; 220(2):271-80. PubMed ID: 21315766 [TBL] [Abstract][Full Text] [Related]
16. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat. Hammond DL; Wang H; Nakashima N; Basbaum AI J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201 [TBL] [Abstract][Full Text] [Related]
18. Peony glycosides produce antidepressant-like action in mice exposed to chronic unpredictable mild stress: effects on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor. Mao QQ; Ip SP; Ko KM; Tsai SH; Che CT Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1211-6. PubMed ID: 19596036 [TBL] [Abstract][Full Text] [Related]
19. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice. Lindholm JS; Autio H; Vesa L; Antila H; Lindemann L; Hoener MC; Skolnick P; Rantamäki T; Castrén E Neuropharmacology; 2012 Jan; 62(1):391-7. PubMed ID: 21867718 [TBL] [Abstract][Full Text] [Related]
20. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Duman CH; Schlesinger L; Kodama M; Russell DS; Duman RS Biol Psychiatry; 2007 Mar; 61(5):661-70. PubMed ID: 16945347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]